organization · Reporting owner
METP Holdings LLC
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Petros Pharmaceuticals, Inc.PTPI · Entity 8730 | 10% owner | December 22, 2021 | January 03, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Petros Pharmaceuticals, Inc.
Report date December 22, 2021 · Filed January 03, 2022
Jointly reported with SHULMAN JOHN D, JCP III SM AIV, L.P., Juggernaut Partners III GP, L.P., Juggernaut Partners III GP, Ltd.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.0001 per shareSEC Table I · non-derivative | IndirectSee Footnote | 5,703,544 |
Reported balance
After 2021-12-22 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2021-12-22 · Purchase · Acquired 145,773 · Balance 5,703,544 F1: See Note (1) in Exhibit 99.1. |
| WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $3.50 · Expires 2026-12-28 | IndirectSee Footnote | 109,329 |
Reported balance
After 2021-12-22 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2021-12-22 · Purchase · Acquired 109,329 · Balance 109,329 F1: See Note (1) in Exhibit 99.1. |
Filing footnotes · ownership attribution and instrument terms
F1: See Note (1) in Exhibit 99.1.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 22, 2021 Filed Jan 3, 2022 06:13 UTC | Petros Pharmaceuticals, Inc. PTPI · Entity 8730 | PurchaseWarrant · Derivative | 109,329 | $0.00 Strike: $3.50 | $0.00 |
DisclosureSEC source: 0001104659-22-000036 · tm2136682-1_4seq1.xml · derivative · entry 2 SHULMAN JOHN D · CIK 0001208886 · Director · 10% owner JCP III SM AIV, L.P. · CIK 0001835386 · 10% owner METP Holdings LLC · CIK 0001836319 · 10% owner Juggernaut Partners III GP, L.P. · CIK 0001835421 · 10% owner Juggernaut Partners III GP, Ltd. · CIK 0001835433 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 109,329 Underlying: Common Stock · 109,329 shares Expires 2026-12-28 F1 · ownership.nature: See Note (1) in Exhibit 99.1. Read SEC document |
| December 22, 2021 Filed Jan 3, 2022 06:13 UTC | Petros Pharmaceuticals, Inc. PTPI · Entity 8730 | PurchaseCommon Stock, par value $0.0001 per share | 145,773 | $3.43 | $500,001.39 |
DisclosureSEC source: 0001104659-22-000036 · tm2136682-1_4seq1.xml · nonDerivative · entry 1 SHULMAN JOHN D · CIK 0001208886 · Director · 10% owner JCP III SM AIV, L.P. · CIK 0001835386 · 10% owner METP Holdings LLC · CIK 0001836319 · 10% owner Juggernaut Partners III GP, L.P. · CIK 0001835421 · 10% owner Juggernaut Partners III GP, Ltd. · CIK 0001835433 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 5,703,544 F1 · balance_after: See Note (1) in Exhibit 99.1. F1 · ownership.nature: See Note (1) in Exhibit 99.1. Read SEC document |
| November 29, 2021 Filed Nov 30, 2021 14:49 UTC | Petros Pharmaceuticals, Inc. PTPI · Entity 8730 | PurchaseWarrant · Derivative | 375,000 | $0.00 Strike: $3.50 | $0.00 |
DisclosureSEC source: 0001104659-21-144901 · tm2134252-1_4.xml · derivative · entry 2 SHULMAN JOHN D · CIK 0001208886 · Director · 10% owner JCP III SM AIV, L.P. · CIK 0001835386 · 10% owner METP Holdings LLC · CIK 0001836319 · 10% owner Juggernaut Partners III GP, L.P. · CIK 0001835421 · 10% owner Juggernaut Partners III GP, Ltd. · CIK 0001835433 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 375,000 Underlying: Common Stock · 375,000 shares Expires 2026-12-02 F1 · ownership.nature: See Note (1) in Exhibit 99.1. Read SEC document |
| November 29, 2021 Filed Nov 30, 2021 14:49 UTC | Petros Pharmaceuticals, Inc. PTPI · Entity 8730 | PurchaseCommon Stock, par value $0.0001 per share | 500,000 | $3.00 | $1,500,000.00 |
DisclosureSEC source: 0001104659-21-144901 · tm2134252-1_4.xml · nonDerivative · entry 1 SHULMAN JOHN D · CIK 0001208886 · Director · 10% owner JCP III SM AIV, L.P. · CIK 0001835386 · 10% owner METP Holdings LLC · CIK 0001836319 · 10% owner Juggernaut Partners III GP, L.P. · CIK 0001835421 · 10% owner Juggernaut Partners III GP, Ltd. · CIK 0001835433 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 5,557,771 F1 · balance_after: See Note (1) in Exhibit 99.1. F1 · ownership.nature: See Note (1) in Exhibit 99.1. Read SEC document |
| October 18, 2021 Filed Oct 21, 2021 08:47 UTC | Petros Pharmaceuticals, Inc. PTPI · Entity 8730 | PurchaseWarrant · Derivative | 1,661,807 | $0.00 Strike: $1.72 | $0.00 |
DisclosureSEC source: 0001567619-21-018515 · doc1.xml · derivative · entry 2 SHULMAN JOHN D · CIK 0001208886 · Director · 10% owner JCP III SM AIV, L.P. · CIK 0001835386 · 10% owner METP Holdings LLC · CIK 0001836319 · 10% owner Juggernaut Partners III GP, L.P. · CIK 0001835421 · 10% owner Juggernaut Partners III GP, Ltd. · CIK 0001835433 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,661,807 Underlying: Common Stock · 1,661,807 shares Expires 2026-10-18 F1 · ownership.nature: See Note (1) in Exhibit 99.1. Read SEC document |
| October 18, 2021 Filed Oct 21, 2021 08:47 UTC | Petros Pharmaceuticals, Inc. PTPI · Entity 8730 | PurchaseCommon Stock, par value $0.0001 per share | 1,661,807 | $1.72 | $2,849,999.01 |
DisclosureSEC source: 0001567619-21-018515 · doc1.xml · nonDerivative · entry 1 SHULMAN JOHN D · CIK 0001208886 · Director · 10% owner JCP III SM AIV, L.P. · CIK 0001835386 · 10% owner METP Holdings LLC · CIK 0001836319 · 10% owner Juggernaut Partners III GP, L.P. · CIK 0001835421 · 10% owner Juggernaut Partners III GP, Ltd. · CIK 0001835433 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 5,057,771 F1 · balance_after: See Note (1) in Exhibit 99.1. F2 · balance_after: Includes 185,414 shares of Common Stock previously held of record by Metuchen Therapeutics, LLC ("MT") that were received by JCP III SM AIV, L.P. as a liquidating distribution. In prior reports, the reporting persons beneficially owned the 185,414 previously held by MT. F1 · ownership.nature: See Note (1) in Exhibit 99.1. Read SEC document |
| December 01, 2020 Filed Dec 28, 2020 19:46 UTC Amendment | Petros Pharmaceuticals, Inc. PTPI · Entity 8730 | GrantCommon Stock, par value $0.0001 per share | 3,395,964 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001567619-20-021618 · doc1.xml · nonDerivative · entry 1 SHULMAN JOHN D · CIK 0001208886 · Director · 10% owner Juggernaut Partners III GP, L.P. · CIK 0001835421 · 10% owner Juggernaut Partners III GP, Ltd. · CIK 0001835433 · 10% owner METP Holdings LLC · CIK 0001836319 · 10% owner JCP III SM AIV, L.P. · CIK 0001835386 · 10% owner Metuchen Therapeutics, LLC · CIK 0001836798 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 3,395,964 F1 · shares: This amended Form 4 is being filed to add Reporting Persons and to adjust the number of securities acquired to account for the same. F2 · price: See Note (1) in Exhibit 99.1. F3 · ownership.nature: See Note (2) in Exhibit 99.1. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.